Review Article

The Proportion of Regulatory T Cells in Patients with Systemic Lupus Erythematosus: A Meta-Analysis

Table 2

Subgroup analysis based on different definitions of Tregs in PB of patients with SLE.

Definition of TregsNumber of studiesTest of associationTest of heterogeneityEgger’s test
SMDa95% CI value2 value

Single CD25-positive18−1.428(−1.982, −0.873)<0.00193.4<0.001−4.290.001
CD25+9−1.512(−2.488, −0.535)0.00293.9<0.001−4.200.004
CD25bright2−3.495(−9.197, 2.207)0.23097.9<0.001
CD25high7−1.074(−1.830, −0.318)0.00592.0<0.001−4.280.008
Associated with FOXP3-positive29−0.043(−0.641, 0.554)0.88796.3<0.0010.550.585
CD25low/−FOXP3+45.275(1.415, 9.136)0.00798.3<0.0014.050.056
FOXP3+21.377(0.124, 2.631)0.03180.10.025
CD25+FOXP3+13−1.142(−1.942, −0.341)0.00595.2<0.001−2.010.069
CD25highFOXP3+10−0.701(−1.283, −0.118)0.01889.6<0.001−0.630.544
Associated with CD127-negative8−1.093(−2.002, −0.183)0.01892.6<0.001−3.050.022
CD25+CD1274−1.128(−1.894, −0.361)0.00481.00.001−1.120.379
CD25bright/highCD127low/−2−12.392(−37.922, 12.138)0.34197.5<0.001
CD25highCD127low/−FOXP3+2−0.667(−2.664, 1.331)0.51396.1<0.001

PB: peripheral blood; SLE: systemic lupus erythematosus; SMD: standard mean difference; CI: confidence interval; 2: -squared index. aMagnitude of Cohen’s effect size (SMD): 0.2–0.5, small effect; 0.5–0.8, medium effect; ≥0.8, large effect.